Annovis Bio Inc (ANVS)

[grich1]

Excerpt from 2021 article regarding Parkinson’s trial.

“I don’t want to sound cocky, but I really do not see any challenges ahead for our Phase 3 trial,” she says. “Patients are required to take one pill a day. It is a small dose with no side effects. I have also heard great feedback from patients. One Parkinson’s patient emailed me a while back. He was in his second Phase 2 trial and was not seeing any improvement. When that trial concluded he was able to try our treatment in a third Phase 2 trial. After just two weeks he contacted me to tell me that it worked. Several other patients did so as well. They reported better memory, coordination, and attention span with less shaking. We believe we will see similar results in our Phase 3 trial. We will present our data to the FDA in September and plan to start the Phase 3 trials for both Alzheimer’s and Parkinson’s this winter.”


Might be the reason CEO and Insiders are buying. A lot of drugs are in clinical for multiple indications but how often do they talk about better cognition as a side effect?? Rett, MS, trials? Several Parkinson’s patients are commenting on cognition.